Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.8 EUR | -5.38% | -2.87% | +26.07% |
Mar. 22 | MaaT Pharma Names Chief Business Officer | MT |
Mar. 21 | Maat Pharma SA Appoint Jonathan Chriqui as Chief Business Officer | CI |
Sales 2023 * | 5M 5.39M | Sales 2024 * | 5M 5.39M | Capitalization | 102M 110M |
---|---|---|---|---|---|
Net income 2023 * | -23M -24.81M | Net income 2024 * | -24M -25.89M | EV / Sales 2023 * | 17.9 x |
Net cash position 2023 * | 12.7M 13.7M | Net Debt 2024 * | 20.15M 21.74M | EV / Sales 2024 * | 24.5 x |
P/E ratio 2023 * |
-3.71
x | P/E ratio 2024 * |
-3.51
x | Employees | 51 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 55.62% |
Latest transcript on MaaT Pharma
1 day | -5.38% | ||
1 week | -2.87% | ||
Current month | +10.83% | ||
1 month | +3.53% | ||
3 months | +22.91% | ||
6 months | +61.76% | ||
Current year | +26.07% |
Managers | Title | Age | Since |
---|---|---|---|
Hervé Affagard
FOU | Founder | - | 13-12-31 |
Siân Crouzet
DFI | Director of Finance/CFO | - | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 54 | 13-12-31 | |
Claude Bertrand
BRD | Director/Board Member | 61 | 20-07-15 |
Muriel Prudent
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 8.8 | -5.38% | 2,982 |
24-03-27 | 9.3 | -0.21% | 1,240 |
24-03-26 | 9.32 | +0.87% | 681 |
24-03-25 | 9.24 | +1.54% | 1,129 |
24-03-22 | 9.1 | +3.88% | 1,189 |
Real-time Euronext Paris, March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.07% | 117M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |